In landmark study, immunotherapy boosts survival of advanced Hodgkin lymphoma
A treatment that boosts the immune system to fight cancer increased the 2-year progression-free survival rate for advanced Hodgkin lymphoma patients to 92%, indicating a potential new standard therapy. …